Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Aug 15, 2016 $21.91 $22.22 $21.27 $22.00 369 300
Aug 12, 2016 $18.66 $21.97 $18.66 $21.95 1 136 800
Aug 11, 2016 $17.79 $18.83 $17.51 $18.64 335 600
Aug 10, 2016 $17.96 $18.28 $17.48 $17.53 177 900
Aug 09, 2016 $17.95 $18.17 $17.66 $17.98 148 000
Aug 08, 2016 $18.18 $18.37 $17.78 $17.85 109 200
Aug 05, 2016 $18.61 $18.61 $18.12 $18.18 255 000
Aug 04, 2016 $17.88 $18.80 $17.88 $18.45 281 000
Aug 03, 2016 $17.75 $18.24 $17.37 $18.13 253 200
Aug 02, 2016 $17.65 $18.08 $17.12 $17.89 203 700
Aug 01, 2016 $17.93 $18.21 $17.48 $17.70 211 700
Jul 29, 2016 $17.54 $18.05 $17.39 $17.88 452 300
Jul 28, 2016 $17.80 $18.18 $17.37 $17.61 170 900
Jul 27, 2016 $17.14 $17.89 $17.08 $17.86 276 800
Jul 26, 2016 $17.22 $17.39 $16.90 $17.05 230 500
Jul 25, 2016 $17.96 $17.96 $16.91 $17.22 298 700
Jul 22, 2016 $18.28 $18.28 $17.81 $17.95 150 700
Jul 21, 2016 $18.75 $18.79 $18.14 $18.35 361 100
Jul 20, 2016 $18.64 $18.72 $18.31 $18.61 425 800
Jul 19, 2016 $18.06 $18.60 $17.94 $18.55 998 900
Jul 18, 2016 $16.62 $17.97 $16.58 $17.96 752 800
Jul 15, 2016 $16.55 $16.62 $16.30 $16.52 291 300
Jul 14, 2016 $17.31 $17.33 $16.43 $16.51 269 900
Jul 13, 2016 $18.12 $18.24 $17.19 $17.23 506 300
Jul 12, 2016 $17.68 $18.12 $17.54 $18.00 269 000
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT